Your shopping cart is currently empty

Caffeic acid is a dual inhibitor of 5-lipoxygenase and TRPV1 ion channels.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | $29 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock | In Stock |

| Description | Caffeic acid is a dual inhibitor of 5-lipoxygenase and TRPV1 ion channels. |
| Targets&IC50 | renin:5704 µM, DNA methylation:3.0 μM, Canine distemper virus:23.3 μg/mL (at 1h post infection) |
| In vitro | METHODS: Human A549 cells were treated with Caffeic Acid for 48 h, and cell growth inhibition was measured using MTT assay. RESULTS: Caffeic Acid inhibited the growth of A549 cells (IC50=0.7 mM). [1] METHODS: Human AGS and HCT-116 cells were treated with Caffeic Acid for 96 hours, and cell growth inhibition was detected using MTT assay. RESULTS: Caffeic Acid inhibited the growth of AGS (IC50=129 μM) and HCT-116 (IC50=29.73 μM) cells. [2] |
| In vivo | METHODS: To study the anti-pruritus effect of Caffeic Acid, Caffeic Acid (500 mg/kg) was orally administered to mice induced by histamine and chloroquine. RESULTS: Caffeic acid pretreated mice showed significantly less histamine-induced scratching and chloroquine-induced scratching. [3] |
| Molecular Weight | 180.16 |
| Formula | C9H8O4 |
| Cas No. | 331-39-5 |
| Smiles | C(=CC(O)=O)C1=CC(O)=C(O)C=C1 |
| Relative Density. | 1.2933 g/cm3 (Estimated) |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 250 mg/mL (1387.66 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (27.75 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.